South Korea Microfluidics Market (2025-2030)
The South Korea Microfluidics Market was valued at $492.07 Million in 2025 and projected to reach to $721.13 Million by 2030, representing a compound annual growth rate of CAGR 7.9%. South Korea's microfluidics market is poised for sustained growth through 2030, driven by increasing demand for miniaturized diagnostic devices and the country's commitment to healthcare digitalization.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Microfluidics Market Trends and Insights
- Valued at $492.07 million in 2025, South Korea's market is expected to expand to $721.13 million by 2030, representing a compound annual growth rate of 7.9%.
- This expansion reflects South Korea's strong investment in advanced diagnostic and therapeutic technologies, driven by its robust healthcare infrastructure and innovation-focused economy. The microfluidics sector in South Korea benefits from increasing adoption in point-of-care diagnostics, drug delivery systems, and laboratory automation.
- South Korea's emphasis on precision medicine and personalized healthcare solutions continues to accelerate demand for microfluidic devices and platforms.
- Between 2025 and 2030, South Korea is anticipated to see heightened commercialization of microfluidic technologies across clinical and research applications, supported by government initiatives and private sector collaboration. South Korea's competitive advantage stems from its semiconductor and electronics manufacturing expertise, which translates into advanced microfluidic chip fabrication capabilities.
- South Korea's market growth trajectory underscores the country's commitment to becoming a regional hub for next-generation healthcare innovation and medical device development..
Key Market Statistics
- CAGR (2025-2030) CAGR 7.9%
- Market Size, 2025 ~USD 492.07 Million
- Forecast, 2030 ~USD 721.13 Million
- Country South Korea
South Korea Microfluidics Market Overview
Market Valuation Growth :
South Korea's microfluidics market is valued at $492.07 million in 2025 and is projected to reach $721.13 million by 2030, demonstrating robust expansion driven by healthcare innovation and diagnostic advancement.
Strong CAGR Performance :
The South Korean market exhibits a 7.9% CAGR from 2025-2030, slightly below the global average of 8.3%, reflecting steady but competitive growth within the Asia Pacific region's healthcare technology sector.
Advanced Healthcare Infrastructure :
South Korea's investment in cutting-edge diagnostic and therapeutic technologies positions the country as a leader in microfluidics adoption, supported by government R&D initiatives and private sector innovation.
Asia Pacific Strategic Hub :
As a key growth segment within Asia Pacific healthcare technology, South Korea serves as a critical market for microfluidics applications in point-of-care diagnostics, drug delivery, and personalized medicine.
South Korea Microfluidics Market Dynamics
- The market benefits from strong government support for biotechnology R&D, a highly skilled workforce, and robust manufacturing capabilities that position South Korean companies as both producers and adopters of microfluidic technologies. The expansion trajectory reflects broader trends in personalized medicine, point-of-care testing, and lab-on-chip applications gaining traction in South Korean healthcare facilities.
- With a 7.9% CAGR, the market is expected to attract significant investment from both domestic and international players seeking to capitalize on South Korea's advanced healthcare ecosystem and growing demand for innovative diagnostic solutions..
Related Ecosystem
Analytical And Scientific Instrumentation
- Environmental Testing
- Gas Chromatography
- Polymerase Chain Reaction (PCR)
- Automated Liquid Handling Systems
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- Merck KGaA
Key Takeaways
- South Korea's microfluidics market will grow from $492.07M (2025) to $721.13M (2030) at a 7.9% CAGR.
- South Korea leverages semiconductor expertise to drive advanced microfluidic chip manufacturing and innovation.
- South Korea's precision medicine and personalized healthcare initiatives are primary demand drivers for microfluidic technologies.
- South Korea is emerging as a regional Asia Pacific hub for microfluidic device commercialization and clinical adoption.
Microfluidics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PCR SYSTEMS (Device) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 8.3% from 2025 to 2030 |
| Largest Segment | MICROFLUIDICS-BASED DEVICES (Product) |
| Market Size Base Year (Billions) | ~USD 24.96 (2025) |
| Revenue Forecast (Billions) | ~USD 37.19 (2030) |
| Segments Covered | Product, Device, Type, Material, Application, End User |
South Korea Microfluidics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product
- Microfluidic
- Microfluidic Components
- Microfluidics-Based Devices
By Device
- Droplet & Particle Production System
- Droplet & Particle Production Systems
- Microfluidic Capillary Electrophoresis
- Next-Generation Sequencing Systems
- Ngs Systems
- Other Devices
- Pcr Systems
By Type
- Capillary Electrophoresis
- Cell-Based Assays
- Clinical Diagnostics
- Drug Delivery
- Flow & Pressure Controllers
- Flow & Pressure Sensors
- Genomic Analysis
- Lab Analytics
- Microdispensing
- Microfluidic Chips
- Microfluidic Valves
- Microneedles
- Micropumps
- Microreactors
- Other Microfluidic Components
- Poct
- Point-Of-Care Testing
- Proteomic Analysis
- Veterinary Diagnostics
- Wearable
By Material
- Cyclic Olefin Copolymers
- Glass
- Other Materials
- Polydimethylsiloxane
- Polymethyl Methacrylate
- Silicon
By Application
- Ivd
- Pharmaceutical & Life Science Research
- Therapeutics
By End User
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
Target Audience
- Medical Device Manufacturers : South Korea-focused device makers need market sizing and growth forecasts to plan product development, manufacturing capacity, and market entry strategies for microfluidics-based diagnostic and therapeutic solutions.
- Healthcare Technology Investors : Investment firms targeting South Korea's biotech and healthcare sectors require country-specific market data to evaluate opportunities, assess ROI potential, and identify high-growth microfluidics segments.
- Pharmaceutical & Biotech Companies : South Korean and international pharma firms need localized market intelligence to guide R&D investments, partnership decisions, and commercialization strategies for microfluidic drug delivery and diagnostic platforms.
- Healthcare Facility Administrators : Hospital networks and diagnostic centers in South Korea require market insights to understand technology adoption trends, procurement opportunities, and competitive positioning of microfluidics solutions.
- Government & Policy Makers : South Korean health ministry and innovation agencies need market data to inform healthcare technology policy, R&D funding priorities, and strategic initiatives supporting the microfluidics industry.
Key Companies in the South Korea Microfluidics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| BECKMAN COULTER | United States | Private Company | Chips,Sensors,Valves, |
| RAINDANCE TECHNOLOGIES | United States | Private Company | Chip,Sensor,Valve, |
| HALMA PLC | United Kingdom | Public Company | Sensor,Valve,Pump, |
| X-FAB | Germany | Public Company | Chip,Sensor,Valve, |
| TECHNICOLOR SA | France | Public Company | Chip,Sensor,Valve, |
| MAXCYTE, INC | United States | Public Company | Microfluidic Chips and Cell-Handling Cartridges (linked to ExPERT PAs),Electroporation Instruments (ExPERT ATx, STx, GTx, VLx),Buffers, Software Protocols, and Accessories, |
| DANAHER CORPORATION | United States | Public Company | Microfluidic Chips & Cartridges,Microfluidic Sensors,Microfluidic Valves & Pumps, |
| ILLUMINA, INC. | United States | Public Company | Microfluidic Chips (including flow cells and integrated cartridges),Microfluidic Sensors,Microfluidic Valves and Pumps, |
| BIOMÉRIEUX | France | Public Company | Chip,Sensor,Valve, |
| THERMO FISHER SCIENTIFIC INC. | United States | Public Company | Microfluidic Chips,Sensors,Valves, |
| ABBOTT LABORATORIES | United States | Public Company | Chip,Sensor,Valve, |
| PARKER HANNIFIN CORP | United States | Public Company | Valves,Pumps,Sensors, |
| SMC CORPORATION | United States | Public Company | AI and HPC servers for life-science workloads,Rack-scale solutions for hospital and diagnostic datacenters,Embedded and edge (5G/IoT/Edge) systems, |
| IDEX CORPORATION | United States | Public Company | Pumps,Valves,Sensors, |
| FORTIVE | United States | Public Company | Chip-adjacent instrumentation and test,Sensor and pump calibration tools,Sterilization and instrument tracking (microfluidic-enabled devices), |
| REVVITY, INC. | United States | Public Company | Microfluidic Chips,Sensors,Valves, |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Chip,Sensor,Valve, |
| BIO-RAD LABORATORIES, INC. | United States | Public Company | Chips,Sensors,Valves, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Chip,Sensor,Valve, |
| STANDARD BIOTOOLS | United States | Public Company | Microfluidic Chips & Consumables,Microfluidic Instruments & Systems,Services, Software & Licensing, |
BECKMAN COULTER
Beckman Coulter is a United States-based diagnostics and life sciences company founded in 1935 with 11,900 employees. As a private company, it provides laboratory instruments and reagents for clinical and research applications.
RAINDANCE TECHNOLOGIES
Raindance Technologies is a United States-based private company founded in 2004 with 104 employees. It develops digital PCR and microfluidic technologies for genomic analysis and molecular diagnostics.
HALMA PLC
Halma PLC is a United Kingdom-based public company founded in 1894 with 9,000 employees. It operates as a diversified group providing safety, environmental, and life sciences solutions across multiple markets.
X-FAB
X-FAB is a Germany-based public company founded in 1992 with 4,300 employees. It is a specialty semiconductor foundry providing analog and mixed-signal semiconductor manufacturing services.
TECHNICOLOR SA
Technicolor SA is a France-based public company founded in 1985 with 1,552 employees. It provides media and entertainment technology services including post-production, digital cinema, and content delivery solutions.
MAXCYTE, INC
MaxCyte, Inc. is a United States-based public company founded in 1998 with 91 employees. It develops electroporation technology platforms for cell engineering and therapeutic applications.
DANAHER CORPORATION
Danaher Corporation is a United States-based public company founded in 1969 with 59,000 employees. It operates as a diversified conglomerate providing products and services in life sciences, diagnostics, environmental, and applied solutions.
ILLUMINA, INC.
Illumina, Inc. is a United States-based public company founded in 1998 with 8,625 employees. It is a leading provider of DNA sequencing and array-based solutions for genomic analysis.
BIOMÉRIEUX
bioMérieux is a France-based public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.
THERMO FISHER SCIENTIFIC INC.
Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. It is a global leader in serving science, providing laboratory equipment, reagents, software, and services for research and diagnostics.
ABBOTT LABORATORIES
Abbott Laboratories is a United States-based public company founded in 1888 with 115,000 employees. It is a diversified healthcare company providing pharmaceuticals, diagnostics, nutritional products, and medical devices.
PARKER HANNIFIN CORP
Parker Hannifin Corp is a United States-based public company founded in 1917 with 57,950 employees. It manufactures motion and control technologies including hydraulic, pneumatic, and electromechanical systems.
SMC CORPORATION
SMC Corporation is a United States-based public company founded in 1993 with 6,238 employees. It manufactures pneumatic and electric automation components and systems for industrial applications.
IDEX CORPORATION
IDEX Corporation is a United States-based public company founded in 1987 with 8,700 employees. It provides fluid and metering technologies, dispensing equipment, and safety systems for various industrial and life sciences applications.
FORTIVE
Fortive is a United States-based public company founded in 2015 with 10,000 employees. It operates as a diversified industrial technology conglomerate providing software, services, and equipment for manufacturing and infrastructure.
REVVITY, INC.
Revvity, Inc. is a United States-based public company founded in 1937 with 11,000 employees. It provides analytical instruments, software, and services for life sciences research, diagnostics, and environmental testing.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. It provides analytical instruments, software, and services for life sciences, diagnostics, and chemical analysis.
BIO-RAD LABORATORIES, INC.
Bio-Rad Laboratories, Inc. is a United States-based public company founded in 1952 with 7,450 employees. It manufactures and distributes life science research products and clinical diagnostics solutions.
BECTON, DICKINSON AND COMPANY
Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees. It is a global medical technology company providing medical devices, laboratory equipment, and diagnostic products.
STANDARD BIOTOOLS
Standard Biotools is a United States-based public company founded in 1999 with 387 employees. It develops microfluidic and single-cell analysis technologies for life sciences research and diagnostics.
Reasons to Buy this Report
- Market-Specific Sizing Data : Access precise valuation figures for South Korea's microfluidics market ($492.07M in 2025, $721.13M in 2030) with country-specific CAGR analysis to inform investment and expansion decisions.
- Competitive Positioning Intelligence : Understand South Korea's market performance relative to global trends (7.9% vs 8.3% global CAGR) and identify competitive advantages within the Asia Pacific healthcare technology landscape.
- Localized Growth Drivers : Gain insights into South Korea-specific factors driving microfluidics adoption, including government R&D support, healthcare infrastructure advancement, and domestic manufacturing capabilities.
- Strategic Market Entry Planning : Develop targeted go-to-market strategies for South Korea with country-specific data on market dynamics, growth trajectories, and healthcare technology adoption patterns through 2030.
- Investment Decision Support : Make informed capital allocation decisions with comprehensive South Korea market analysis, enabling confident investment in microfluidics ventures, partnerships, and facility expansion in the region.
Frequently asked questions
What is the current size of South Korea's microfluidics market?
South Korea's microfluidics market is valued at $492.07 million in 2025 and is projected to reach $721.13 million by 2030.
What is the growth rate of South Korea's microfluidics market?
South Korea's microfluidics market is expected to grow at a compound annual growth rate (CAGR) of 7.9% from 2025 to 2030.
What are the primary applications driving South Korea's microfluidics market?
South Korea's microfluidics market is driven by point-of-care diagnostics, drug delivery systems, laboratory automation, and precision medicine applications.
How does South Korea's manufacturing capability support microfluidics growth?
South Korea's advanced semiconductor and electronics manufacturing expertise enables sophisticated microfluidic chip fabrication and commercialization at scale.
What role does government policy play in South Korea's microfluidics market expansion?
South Korea's government initiatives supporting precision medicine, healthcare innovation, and medical device development are key catalysts for microfluidics market growth.
RESEARCH METHODOLOGY
Four main studies were done to estimate the market size of microfluidics. Secondary research was carried out to obtain data associated with the market, peer markets, and parent markets. After that, data was obtained from 3-5 secondary sources; the findings, assumptions, and sizing were confirmed through primary sources. Top-down and bottom-up approaches were utilized to gain insights on complete market size. After that, market breakdown and data triangulation were used to determine the market size of segments and subsegments.
Secondary Research
Directories, databases like D&B Hoovers, Factiva, white papers, Bloomberg Businessweek, annual reports, SEC filings, business filings and investor presentations are few of the important sources used in the secondary research. This helps in gaining fundamental details about prominent companies and market segmentation as per the industry trends at numerous levels and technological viewpoints related with the Microfluidics market.
Primary Research
The primary research compromised performing interviews from both the supply and demand sides to obtain quantitative and qualitative data. CEOs, area sales managers, territory sales managers, regional sales managers and other important officials from top businesses are the primary sources from the supply side. Physicians, researchers, department heads, and staff members from diagnostic centers, hospitals and research institutes were the primary sources from the demand side. The target of this study was to verify the conclusions and assumptions from secondary research by interacting with stakeholders directly.
A breakdown of the primary respondents is provided below:
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = < USD 500 million, and Tier 3 = < USD 100 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The revenue share analysis of the major key players for the size of the Microfluidics market is given in this study. Primary and secondary research are used to find prominent players in the Microfluidics and to gain insights of their financials and market share. The primary research approach comprises extremely in-depth interviews with CEOs, directors, and senior marketing executives, while the secondary research procedure mostly relied on the annual and financial reports of major players. Segment-based technique was used to determine the global market value. The revenue details of significant solution and service suppliers was then applied to source these segmented revenues.
The steps in the procedure are
- List the key global companies that are associated with the Microfluidics industry. Note the annual revenues of the players in the Microfluidics industry or the product category/business division.
- As of 2024, it represents an important portion of the market based on revenue mapping of the key competitors. Extrapolation to the global value for the Microfluidics market.
Data Triangulation
The Microfluidics market was categorized into various segments and subsegments with the help of the above procedure. Then, data triangulation and the market segmentation process are carried out to ensure the accuracy of the data for each segment. Factors and trends from demand and supply sides were studied . Top-down and bottom-up approaches provide the outcome from the analysis of the Microfluidics market.
Market Definition
The microfluidics market includes products and technologies that are developed to analyse and regulate fluid volume through microfluidic devices and components. The market covers both the microfluidics components that are important for the working of microfluidics-based devices, such as lab-on-a-chip systems and diagnostic assays, as well as the devices. Microneedles, micropumps, flow and pressure sensors, controllers, and microfluidic valves are some of the important components of microfluidics-based device.Polymers, silicon, and glass are most often used in the development of these components. The market provides innovative technologies for effective and precise fluid management and analysis, which have beneficial applications in research and diagnostics.
Stakeholders
- Microfluidic product manufacturers
- Microfluidic product distributors
- Pharmaceutical companies
- IVD manufacturers
- In vitro diagnostic test (IVD) distributors
- Research institutes
- Contract manufacturing organizations (CMOs)
- Contract research organizations (CROs)
- Healthcare institutions (hospitals, medical schools, and outpatient clinics)
- Government associations
- Market research and consulting firms
- Venture capitalists and investors
Report Objectives
- To define, describe, and forecast the microfluidics market by product, application, end-user, and region
- To provide detailed information about the key factors influencing the market growth, such as drivers, restraints, opportunities, challenges, and industry trends
- To strategically analyze the regulatory scenario, Porter’s five force analysis, value chain analysis, supply chain analysis, ecosystem map, and patent analysis
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the microfluidics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To profile the prominent players in this market and comprehensively analyze their market shares and core competencies
- To strategically analyze the microfluidics market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as acquisitions, product launches, product approvals, partnerships, and expansions in the microfluidics market
Get the Full Microfluidics Market Report
Full forecast, segment splits, and company analysis for all Microfluidics Market.
- US Microfluidics Market
- Canada Microfluidics Market
- Germany Microfluidics Market
- France Microfluidics Market
- UK Microfluidics Market
- Italy Microfluidics Market
- Spain Microfluidics Market
- China Microfluidics Market
- Japan Microfluidics Market
- India Microfluidics Market
- Australia Microfluidics Market
- Brazil Microfluidics Market
- Mexico Microfluidics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report